Severe Treatment-Induced Arthritis Might Predict Cancer Progression in People on Checkpoint Inhibitors, Study Suggests

Published Oct 18, 2020

Severe Treatment-Induced Arthritis Might Predict Cancer Progression in People on Checkpoint Inhibitors, Study Suggests

In a small study of people on checkpoint inhibitors for several different cancers, those who developed treatment-induced arthritis sooner and more severely were more likely to have cancer progression. More research is needed to confirm this connection.

NOW
PLAYING
Given Just 18 Months to Live, This Lung Cancer Survivor Proves the Power of Clinical Trials
NOW
PLAYING
With Wildfires Raging Across the West Coast a Leading Expert Tells Us How Cancer Patients Can Stay Safe
NOW
PLAYING
Can Having More Sex Reduce Your Risk for Prostate Cancer?
NOW
PLAYING
Which Women with Ovarian Cancer Should Get PARP Inhibitors? New Guidelines Offer Recommendations
NOW
PLAYING
Why Do So Few Black Men Get Colon Cancer Screenings? Closing the Racial Disparity Gap In Cancer at Forefront After Tragic Death of Chadwick Boseman, 43
NOW
PLAYING
FDA Approves Blood Test Which May Let Some Cancer Patients Avoid Additional Biopsies
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.